<SEC-DOCUMENT>0001193125-25-184619.txt : 20250821
<SEC-HEADER>0001193125-25-184619.hdr.sgml : 20250821
<ACCEPTANCE-DATETIME>20250821070038
ACCESSION NUMBER:		0001193125-25-184619
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250816
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250821
DATE AS OF CHANGE:		20250821

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Scilex Holding Co
		CENTRAL INDEX KEY:			0001820190
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39852
		FILM NUMBER:		251238349

	BUSINESS ADDRESS:	
		STREET 1:		960 SAN ANTONIO ROAD
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94303
		BUSINESS PHONE:		(650) 516-4310

	MAIL ADDRESS:	
		STREET 1:		960 SAN ANTONIO ROAD
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94303

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Scilex Holding Company/DE
		DATE OF NAME CHANGE:	20221117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Vickers Vantage Corp. I
		DATE OF NAME CHANGE:	20200804
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d27011d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sclxw="http://imetrix.edgar-online.com/20250816" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2025-08-16_to_2025-08-16">Scilex Holding Co</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-345">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-08-16_to_2025-08-16">0001820190</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="sclxw-20250816.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-08-16_to_2025-08-16"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820190</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-08-16</xbrli:startDate> <xbrli:endDate>2025-08-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-CommonStockParValue0.0001PerShareMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820190</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sclxw:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-08-16</xbrli:startDate> <xbrli:endDate>2025-08-16</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820190</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sclxw:WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-08-16</xbrli:startDate> <xbrli:endDate>2025-08-16</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-372">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-08-16_to_2025-08-16" format="ixt:datemonthdayyearen" id="ixv-373">August 16, 2025</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">SCILEX HOLDING COMPANY</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-08-16_to_2025-08-16" format="ixt-sec:stateprovnameen" id="ixv-374">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-375">001-39852</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-376">92-1062542</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-377">960 San Antonio Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-378">Palo Alto</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-08-16_to_2025-08-16" format="ixt-sec:stateprovnameen" id="ixv-379">California</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-380">94303</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices, including zip code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-381">(650)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-382">516-4310</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-08-16_to_2025-08-16" format="ixt-sec:boolballotbox" id="ixv-383">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-08-16_to_2025-08-16" format="ixt-sec:boolballotbox" id="ixv-384">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-08-16_to_2025-08-16" format="ixt-sec:boolballotbox" id="ixv-385">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-08-16_to_2025-08-16" format="ixt-sec:boolballotbox" id="ixv-386">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-CommonStockParValue0.0001PerShareMember" id="ixv-387">Common stock, par value $0.0001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-CommonStockParValue0.0001PerShareMember" id="ixv-388">SCLX</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="ixv-389">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" id="ixv-390">Warrants to purchase common stock at an exercise price of $402.50 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" id="ixv-391">SCLXW</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" format="ixt-sec:exchnameen" id="ixv-392">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-08-16_to_2025-08-16" format="ixt-sec:boolballotbox" id="ixv-393">&#9746;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2025-08-16_to_2025-08-16" format="ixt-sec:boolballotbox" id="ixv-394">&#9746;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Resignation of Chief Executive Officer and President </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;16, 2025, Jaisim Shah, Chief Executive Officer and President of Scilex Holding Company (the &#8220;Company&#8221;) notified the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) that he was resigning from his positions as Chief Executive Officer and President, effective as of August&#160;17, 2025 (the &#8220;Effective Time&#8221;). Mr.&#160;Shah will remain a member of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Shah will continue to serve as Chief Executive Officer and President of Semnur Pharmaceuticals, Inc. (&#8220;Semnur&#8221;), a majority owned subsidiary of the Company, and as a member of the board of directors of Semnur. Mr.&#160;Shah is the <span style="white-space:nowrap">co-founder</span> of Semnur and his decision to resign as the Company&#8217;s Chief Executive Officer and President of the Company was driven by his desire to focus fully on Semnur&#8217;s business, and particularly the development of <span style="white-space:nowrap">SP-102.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Appointment of Chief Executive Officer and President </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&#160;Shah&#8217;s resignation, on August&#160;17, 2025, the Board appointed Henry Ji, Ph.D., age 61, as the Company&#8217;s Chief Executive Officer and President as of the Effective Time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&#160;Ji has served as the Executive Chairperson and a member of the Board since September&#160;22, 2023 and previously served as the Company&#8217;s Executive Chairperson and a member of the Board from November 2022 to August 2023. Prior to that, he served as Executive Chairperson and a board member of the private Delaware corporation that is now a wholly owned subsidiary of the Company, named Scilex, Inc.,&#160;from March 2019 to November 2022. Dr.&#160;Ji has served on the board of directors of Scilex Pharmaceuticals, Inc. (&#8220;Scilex Pharma&#8221;) since November 2016 and he served as the Chief Executive Officer of Scilex Pharma from November 2016 to March 2019. Dr.&#160;Ji has served as Semnur&#8217;s Treasurer and Secretary and a board member since its inception in 2013. He currently serves as the Chief Executive Officer of Vivasor Holding Company and Vivasor, Inc. He <span style="white-space:nowrap">co-founded</span> and has served as a director of Sorrento Therapeutics, Inc. (&#8220;Sorrento&#8221;) since January 2006, served as its Chief Executive Officer and President since September 2012 and as Chairman of its board of directors since August 2017. In 2002, Dr.&#160;Ji founded BioVintage, Inc., a research and development company focusing on innovative life sciences technology and product development, and has served as its President since 2002. From 2001 to 2002, Dr.&#160;Ji served as Vice&#160;President of CombiMatrix Corporation, a publicly-traded biotechnology company that develops proprietary technologies, including products and services in the areas of drug development, genetic analysis, molecular diagnostics and nanotechnology. During his tenure at CombiMatrix Corporation, Dr.&#160;Ji was responsible for strategic technology alliances with biopharmaceutical companies. From 1999 to 2001, Dr.&#160;Ji served as Director of Business Development, and in 2001 as Vice President of Stratagene Corporation (later acquired by Agilent Technologies, Inc.) where he was responsible for novel technology and product licensing and development. In 1997, Dr.&#160;Ji <span style="white-space:nowrap">co-founded</span> Stratagene Genomics, Inc., a wholly owned subsidiary of Stratagene Corporation, and served as its President and Chief Executive Officer from its founding until 1999. Dr.&#160;Ji previously served as a director of Celularity Inc. (Nasdaq: CELU) from June 2017 to July 2021. Dr.&#160;Ji is the holder of several issued and pending patents in the life science research field and is the sole inventor of Sorrento&#8217;s intellectual property. Dr.&#160;Ji has a Ph.D. in Animal Physiology from the University of Minnesota and a B.S. in Biochemistry from Fudan University. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships between Dr.&#160;Ji and any director or other executive officer of the Company, nor are there any transactions to which the Company was or is a participant and in which Dr.&#160;Ji has a material interest subject to disclosure under&#160;Item 404(a) <span style="white-space:nowrap">of&#160;Regulation&#160;S-K,</span> other than as disclosed below. There are no arrangements or understandings between Dr.&#160;Ji and any other person pursuant to which he was selected as Chief Executive Officer and President. The Company previously entered into its standard form of indemnification agreement with Dr.&#160;Ji in connection with his prior appointment as Executive Chairman. Dr.&#160;Ji&#8217;s compensation has not been changed in connection his appointment as the Company&#8217;s Chief Executive Officer and President. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Certain Relationships and Related Party Transactions of Dr.&#160;Ji </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since January&#160;1, 2023, the Company has entered into the following transactions in which Dr.&#160;Ji may be deemed to have a direct or indirect material interest, based on his role as an executive officer and director of Sorrento Therapeutics, Inc. (which is a counter-party to the below-referenced transactions) at the time such transactions were entered into. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Stockholder Agreement with Sorrento </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;12, 2022, Vickers entered into the Stockholder Agreement with Sorrento (the &#8220;Stockholder Agreement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Stockholder Agreement, from and after its effectiveness, and for so long as Sorrento together with its affiliates, subsidiaries, successors and assigns (other than the Company and its subsidiaries) (the &#8220;Sorrento Group&#8221;) beneficially owns any shares of Series A Preferred Stock, among other things, (i)&#160;Sorrento had the right, but not the obligation, to designate each director to be nominated, elected or appointed to the Board (each, a &#8220;Stockholder Designee&#8221; and collectively, the &#8220;Stockholder Designees&#8221;), regardless of whether such Stockholder Designee is to be elected to the Board at a meeting of stockholders called for the purpose of electing directors (or by consent in lieu of meeting) or appointed by the Board in order to fill any vacancy created by the departure of any director or increase in the authorized number of members of the Board or the size of the Board and (ii)&#160;the Company were required to take all actions reasonably necessary, and not otherwise prohibited by applicable law, to cause each Stockholder Designee to be so nominated, elected or appointed to the Board as more fully described in the Stockholder Agreement. Notwithstanding the foregoing, the parties previously agreed that the Board will continue to satisfy all applicable stock exchange requirements applicable to directors, including with respect to director independence. Sorrento also had the right to designate a replacement director for any Stockholder Designee that has been removed from the Board and the right to appoint a representative of Sorrento to attend all meetings of the committees of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Stockholder Agreement also provided that the Company shall not, and shall cause its subsidiaries not to, among others, without the prior written consent of Sorrento: (i)&#160;amend, alter, modify or repeal (whether by merger, consolidation, by operation of law or otherwise) any provisions of the Certificate of Incorporation (including the Certificate of Designations of Series A Preferred Stock, filed with the Secretary of State of the State of Delaware on November&#160;10, 2022 (the &#8220;Series A Certificate of Designations&#8221;)) or Bylaws that increase or decrease the authorized number of directors constituting the Board; (ii)&#160;take any action that would have the effect of increasing or decreasing the number of directors constituting the Board; (iii)&#160;amend, alter, modify or repeal (whether by merger, consolidation, reclassification, by operation of law or otherwise) any provisions of the respective charters (and any related organizational documents) of any of the committees of the Board; (iv)&#160;file any voluntary petition under any applicable federal or state bankruptcy or insolvency law on behalf of the Company or any of its subsidiaries; (v)&#160;(A) incur or permit any of the Company&#8217;s subsidiaries to incur any indebtedness in an aggregate principal amount in excess of $10,000,000) (with &#8220;principal amount&#8221; for purposes of this definition to include undrawn committed or available amounts) or (B)&#160;enter into, modify, amend or renew (or permit any of the Company&#8217;s subsidiaries enter into, modify, amend or renew) any contract or other agreement in respect of indebtedness in an aggregate principal amount in excess of $10,000,000 (with &#8220;principal amount&#8221; for purposes of this definition to include undrawn committed or available amounts); (vi) consummate or otherwise enter into any other contract or agreement to effect any change of control, joint venture or corporate reorganization by the Company or any of the Company&#8217;s subsidiaries; (vii)&#160;declare or pay any dividend or distribution on the Company&#8217;s Common Stock, other Junior Security (as defined below) or Parity Security (as defined below); or (viii)&#160;purchase, redeem or otherwise acquire for consideration by us, directly or indirectly, any Common Stock, other Junior Security or Parity Security (except as necessary to effect (A)&#160;a reclassification of any Junior Security for or into other Junior Securities, (B)&#160;a reclassification of any Parity Security for or into other Parity Securities with the same or lesser aggregate liquidation preference, (C)&#160;a reclassification of any Parity Security into a Junior Security, (D)&#160;the exchange or conversion of any Junior Security for or into another Junior Security, (E)&#160;the exchange or conversion of any Parity Security for or into another Parity Security with the same or lesser per share liquidation amount, (F)&#160;the exchange or conversion of any Parity Security for or into any Junior Security or (G)&#160;the settlement of incentive equity awards (including any applicable withholdings and the net exercise of options) in accordance with the terms thereof). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A Preferred Stock ranks (i)&#160;senior to all of the Company&#8217;s Common Stock, and to all other classes or series of the Company&#8217;s capital stock, except for any such other class or series, the terms of which expressly provide that it ranks on parity with the Series A Preferred Stock as to dividend rights and rights on liquidation, dissolution or <span style="white-space:nowrap">winding-up</span> of the Company (&#8220;Junior Securities&#8221;); and (ii)&#160;on parity with each class or series of the Company&#8217;s capital stock, created specifically ranking by its terms on parity with the Series A Preferred Stock as to dividend rights and rights on liquidation, dissolution or <span style="white-space:nowrap">winding-up</span> of the Company (&#8220;Parity Securities&#8221;). </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After a hearing before the Bankruptcy Court on September&#160;12, 2023, the Bankruptcy Court entered a final order approving, among other things, the termination of the Stockholder Agreement, upon the closing of the Equity Repurchase Transaction (as defined below). Accordingly, the Stockholder Agreement terminated on September&#160;21, 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Junior <span style="white-space:nowrap"><span style="white-space:nowrap">Debtor-in-Possession</span></span> Financing with Sorrento </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Background </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our former controlling stockholder, Sorrento, together with its wholly owned direct subsidiary, Scintilla Pharmaceuticals, Inc. (together with Sorrento, the &#8220;Debtors&#8221;), commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code (the &#8220;Bankruptcy Code&#8221;) in the Bankruptcy Court. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After a hearing before the Bankruptcy Court on March&#160;29, 2023, the Bankruptcy Court entered a final order approving a <span style="white-space:nowrap">non-amortizing</span> super-priority senior secured term loan facility in an aggregate principal amount not to exceed $75,000,000 in term loan commitments (the &#8220;Senior DIP Facility&#8221;), provided to the Debtors by JMB Capital Partners Lending, LLC (the &#8220;Senior DIP Lender&#8221;), on a final basis. The Debtors then negotiated definitive financing documentation, including a Senior Secured, Super-Priority <span style="white-space:nowrap"><span style="white-space:nowrap">Debtor-in-Possession</span></span> Loan and Security Agreement and other documents evidencing the Senior DIP Facility. At the time of the entry of the Interim DIP Order (as defined below), the Debtors&#8217; liquidity was projected to last only until July&#160;7, 2023. The Senior DIP Facility matured on July&#160;31, 2023 and was not repaid on such date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2023, the Debtors filed the Debtors&#8217;<span style="font-style:italic">&#160;Emergency Motion for Entry of Interim and Final Orders (I)</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Authorizing the Debtors to (A)</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Obtain Junior Secured Superpriority Postpetition Financing and (B)</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Use Cash Collateral, (II)</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Granting Liens and Providing Claims with Superpriority Administrative Expense Status, (III)</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Modifying the Automatic Stay, (IV)</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Scheduling a Final Hearing, and (V)</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Granting Related Relief</span>&#160;(the &#8220;DIP Motion&#8221;), seeking the Bankruptcy Court&#8217;s approval of the Junior DIP Facility (as defined below) and certain related relief. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Terms of the Junior DIP Facility </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;5, 2023, the Company and the Debtors executed that certain <span style="white-space:nowrap"><span style="white-space:nowrap">Debtor-in-Possession</span></span> Term Loan Facility Summary of Terms and Conditions (the &#8220;Junior DIP Term Sheet&#8221;), pursuant to which the Company (or its designees or its assignees) agreed to provide the Debtors with a <span style="white-space:nowrap">non-amortizing</span> super-priority junior secured term loan facility in an aggregate principal amount not to exceed the sum of (i) $20,000,000 (the &#8220;Base Amount&#8221;), plus (ii)&#160;the amount of the commitment fee and the funding fee, each equal to 1% of the Base Amount, plus (iii)&#160;the amount of the DIP Lender Holdback (as defined in the Interim DIP Order) (the &#8220;Junior DIP Facility&#8221;), subject to the terms and conditions set forth in the Junior DIP Term Sheet. The Junior DIP Term Sheet granted to the Company a right of first refusal to provide any <span style="white-space:nowrap"><span style="white-space:nowrap">debtor-in-possession</span></span> financing during the course of the Chapter 11 Cases to the Debtors occurring after the date of the Interim DIP Order until the Chapter 11 Cases were concluded. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The interest rate under the Junior DIP Facility was 12.00% per annum payable in kind on the first day of each month in arrears and on the DIP Termination Date (as defined in the Junior DIP Term Sheet). Upon the occurrence and during the continuance of an event of default as defined in the Junior DIP Term Sheet, the interest rate on outstanding DIP Loans (as defined in the Junior DIP Term Sheet) would increase by 2.00% per annum (payable in kind). The commitment fee and the funding fee described above became payable upon the funding of the DIP Loans (as defined in the Junior DIP Term Sheet), in each case as set forth in the Junior DIP Term Sheet. Upon repayment or satisfaction of the DIP Loans (as defined in the Junior DIP Term Sheet) in whole or in part, the Debtors were to pay to the Company in cash an exit fee equal to 2.00% of the aggregate principal amount of the Junior DIP Facility on the date of the Draw (as defined below). The Junior DIP Facility terms state that it was required to be paid in full in cash under any Chapter 11 plan of reorganization. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The interest rate return on the Senior DIP Lender was 14.0% on an annual basis. Based on the terms of the Junior DIP Facility and the Senior DIP Facility including the fees associated therewith, respectively, the Company believe that </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the annualized returns to the Senior DIP Lender exceeded the returns to the Junior DIP Lender as a result of the differences in the following between the Senior DIP Facility and the Junior DIP Facility, respectively: <span style="white-space:nowrap">(i)&#160;non-default</span> annualized interest rate of 14.0% as compared to 12.0%; (ii) maturity term of five months as compared to three months; (iii)&#160;a commitment fee of 2.5% as compared to 1.0%; (iv) a funding fee of 2.5% as compared to 1.0%; and (v)&#160;an exit fee of 7.0% as compared to 2.0%. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Junior DIP Facility was set to mature on the earliest of: (i)&#160;September&#160;30, 2023; (ii) the effective date of any Chapter 11 plan of reorganization with respect to the Debtors; (iii)&#160;the consummation of any sale or other disposition of all or substantially all of the assets of the Debtors pursuant to section 363 of the Bankruptcy Code; (iv)&#160;the date of the acceleration of the DIP Loans and the termination of the DIP Commitments in accordance with the DIP Documents (each as defined in the Junior DIP Term Sheet); and (v)&#160;dismissal of the Chapter 11 Cases or conversion of the Chapter 11 Cases into cases under Chapter 7 of the Bankruptcy Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Junior DIP Facility afforded the Company certain valuable protections. First, the Junior DIP Facility was secured by liens on and security interests in substantially all assets of Sorrento, other than certain excluded assets as described more fully in the Interim DIP Order, including (i)&#160;a first-priority security interest in and continuing lien on all proceeds of the DIP Facility in the DIP Accounts, and the Junior DIP Lender Holdback (each as defined in the Interim DIP Order) and (ii)&#160;subject to certain terms and exclusions, a second-priority security interest in and continuing lien on substantially all other assets, in each case, whether then owned or existing or thereafter acquired, created or arising and wherever located other than certain excluded assets as described in the Interim DIP Order. The Junior DIP Facility was also granted super priority administrative expense priority ahead of certain other administrative expenses in Chapter 11 and ahead of <span style="white-space:nowrap">pre-petition</span> unsecured claims, which means it had to be paid in full, in cash in order for the Debtors to emerge from bankruptcy under a Chapter 11 Plan, unless otherwise agreed to by us. This priority status gave the Company a voice in Sorrento&#8217;s plan to emerge from Chapter 11. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of that certain intercreditor and subordination agreement, dated as of September&#160;21, 2023, entered into by and among the Senior DIP Lender and the Company (the &#8220;Intercreditor and Subordination Agreement&#8221;), the Debtors&#8217; obligations to the Company under the Junior DIP Facility were subordinated to the obligations of the Debtors to Senior DIP Lender on the terms and conditions set forth therein. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;5, 2023, at a hearing before the Bankruptcy Court, the Bankruptcy Court entered an interim order (the &#8220;Interim DIP Order&#8221;) approving the Junior DIP Facility among the Debtors (as borrowers) and the Company (as lender) on an interim basis. Upon entry of the Interim DIP Order and satisfaction of all applicable conditions precedent, as set forth in the Junior DIP Term Sheet, the Debtors were authorized to make a single draw under the Junior DIP Facility (the &#8220;Draw&#8221;) to be funded by the Company as the lender under the Junior DIP Facility.. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bankruptcy Court entered the final order approving on the Junior DIP Facility on July&#160;27, 2023. Other definitive financing documentation was then negotiated, including a Junior Secured, Super Priority <span style="white-space:nowrap"><span style="white-space:nowrap">Debtor-in-Possession</span></span> Loan and Security Agreement, which was entered into on July&#160;28, 2023 between the Company and the Debtors (the &#8220;Junior DIP Loan Agreement&#8221;), which agreement memorialized the terms of the Junior DIP Term Sheet. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After a hearing before the Bankruptcy Court on August&#160;7, 2023, the Bankruptcy Court on August&#160;7, 2023, entered a final order (the &#8220;Replacement DIP Order&#8221;) approving a <span style="white-space:nowrap">non-amortizing</span> super-priority <span style="white-space:nowrap"><span style="white-space:nowrap">debtor-in-possession</span></span> term loan facility in an aggregate principal amount of $100,000,000 (the &#8220;Replacement DIP Facility&#8221;) provided to the Debtors by Oramed Pharmaceuticals Inc. on a final basis. The Replacement DIP Facility was to be used to, among other things, refinance the existing Senior DIP Facility. The Replacement DIP Facility included certain milestones for the sale of the Company&#8217;s equity interests owned by the Debtors. The lender under the Replacement DIP Facility was permitted to use the loan to credit bid for the collateral securing the Replacement DIP Facility (including the equity interests of the Company), subject to the terms therein. The Replacement DIP Order provided that the liens securing the Junior DIP Facility were junior to the liens securing the Replacement DIP Facility and the Company was not permitted to exercise certain remedies until the payment in full of the Replacement DIP Facility (all as set forth in the Replacement DIP Order). Though junior to the Replacement DIP Facility, the Company would still have been treated as a secured creditor with priority over other claimants in the Chapter 11 Cases. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We funded the Junior DIP Facility with cash on hand, including from a portion of the net proceeds from the eCapital Credit Agreement that were distributed to the Company by the Company&#8217;s wholly owned subsidiary, Scilex Pharma. The Junior DIP Facility was terminated on September&#160;21, 2023, pursuant to a <span style="white-space:nowrap">Pay-Off</span> Letter. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Stock Purchase Agreement with Sorrento </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;21, 2023, in connection with the securities purchase agreement entered into with Oramed Pharmaceuticals Inc., the Company and Sorrento entered into and consummated the Equity Repurchase Transaction contemplated by the Stock Purchase Agreement, dated September&#160;21, 2023, between the Company and Sorrento (the &#8220;Sorrento SPA&#8221;), pursuant to which, among other things, the Company purchased from Sorrento (i) 1,716,245 shares of Common Stock, (ii) 29,057,097 shares of Series A Preferred Stock, and (iii)&#160;warrants exercisable for 128,304 shares of Common Stock, each with an exercise price of $402.50 per whole share ((i) through (iii)&#160;collectively, the &#8220;Purchased Securities&#8221;). The aggregate consideration for the Purchased Securities was (i) $100,000,000 (the &#8220;DIP Amount&#8221;), which such amount is satisfied by the Company&#8217;s assumption of the Debtors&#8217; outstanding obligations under the Senior DIP Facility (the &#8220;Oramed DIP Assumption&#8221;), (ii) a credit bid, on a <span style="white-space:nowrap"><span style="white-space:nowrap">dollar-for-dollar</span></span> basis, pursuant to Section&#160;363(k) of the Bankruptcy Code, in respect of any and all amounts of principal and accrued but unpaid interest outstanding, and any other obligations of the Debtors, in each case, under the Junior DIP Facility as of September&#160;21, 2023 (the &#8220;Credit Bid Amount&#8221;), (iii) $10,000,000 in cash (the &#8220;Cash Payment&#8221;) and (iv)&#160;the assumption and assignment of certain obligations of Sorrento for legal fees and expenses in the approximate amount of $12.25&#160;million (the &#8220;Legal Fee Assumption&#8221; and, together with the DIP Amount, the Credit Bid Amount and the Cash Payment, the &#8220;Purchase Price&#8221;). Following the sale of the Purchased Securities, Sorrento retained 54,777 shares of Common Stock in abeyance for the benefit of certain holders of warrants to purchase shares of common stock of Sorrento who may be entitled to receive shares of Common Stock pursuant to the terms of the applicable warrants as a result of the previously declared and announced dividend of shares of Common Stock by Sorrento. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Credit Bid <span style="white-space:nowrap">Pay-Off</span> Letter </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Sorrento SPA, in connection with acquiring the Purchased Securities, the Company made a credit bid, on a <span style="white-space:nowrap"><span style="white-space:nowrap">dollar-for-dollar</span></span> basis, pursuant to Section&#160;363(k) of the Bankruptcy Code, in respect of the obligations of the Debtors under the Junior DIP Loan Agreement, accrued and outstanding as of September&#160;21, 2023 for the Credit Bid Amount. As noted above, the Credit Bid Amount is part of the Purchase Price for the Purchased Securities. On September&#160;21, 2023, the Company entered into a letter agreement (the <span style="white-space:nowrap">&#8220;Pay-Off</span> Letter&#8221;) with the Debtors, pursuant to which, upon Closing (as defined in the Sorrento SPA), the Junior DIP Loan Agreement, that certain Intellectual Property Security Agreement, dated as of July&#160;28, 2023, by the Debtors in the Company&#8217;s favor, any other Loan Document (as defined in the Junior DIP Loan Agreement) and any other notes, security agreements, mortgages, pledge agreements, guarantees or other agreements, documents, certificates or instruments related thereto automatically terminated, and all obligations thereunder were paid and discharged in full. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Legal Fee Assumption Letter Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Legal Fee Assumption in accordance with the Sorrento SPA, the Company and Sorrento entered into a letter agreement on September&#160;21, 2023, pursuant to which, among other things, the Company agreed to assume all of Sorrento&#8217;s obligations for certain legal fees and expenses in the aggregate amount of approximately $12.25&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;21, 2025, the Company issued a press release announcing, among other things, the management changes described in Item 5.02 of this Current Report on Form <span style="white-space:nowrap">8-K.</span> A copy of this press release is furnished with this report as Exhibit 99.1 and incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;9.01. Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:6%"/>
<td style="width:91%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Exhibit<br/>Number&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d27011dex991.htm">Press Release, dated August&#160;21, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).</td></tr>
</table> <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">


<tr>

<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:87%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">SCILEX HOLDING COMPANY</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">/s/ Henry Ji</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Henry Ji</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer&#160;&amp; President</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: August 21, 2025 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d27011dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">


<IMG SRC="g27011g0821034745545.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FOR IMMEDIATE RELEASE</B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>August&nbsp;21, 2025</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc.
(&#8220;Semnur&#8221;), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.00 per share and Jaisim Shah, Scilex&#8217;s CEO and President, Will be Dedicated to
Semnur on a Full Time Basis to Rapidly Advance <FONT STYLE="white-space:nowrap">SP-102</FONT> to Regulatory Approval and Commercialization for the Treatment of Lumbosacral Radicular Pain (LRP)/Sciatica </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PALO ALTO, CALIFORNIA &#8211; August</B><B></B><B>&nbsp;21, 2025 (GLOBE NEWSWIRE) - </B>Scilex Holding Company (&#8220;Scilex&#8221; or the
&#8220;Company&#8221;) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing <FONT STYLE="white-space:nowrap">non-opioid</FONT> pain management products for the treatment of acute and chronic
pain and neurodegenerative and cardiometabolic disease, today announced that its majority-owned subsidiary, Semnur Pharmaceuticals, Inc. (&#8220;Semnur&#8221;), and Denali Capital Acquisition Corp (&#8220;Denali&#8221;) have entered into a purchase
agreement (&#8220;Purchase Agreement&#8221;) with an investor for a $20&nbsp;million private placement, the proceeds of which will be used to advance the second Phase 3 clinical trial for the development of
<FONT STYLE="white-space:nowrap">SP-102</FONT> (10 mg, dexamethasone sodium phosphate viscous gel) (&#8220;SEMDEXA<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>&#8221; or <FONT STYLE="white-space:nowrap">&#8220;SP-102&#8221;),</FONT>
for the treatment of LRP/Sciatica. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Purchase Agreement, the investor has agreed to purchase an aggregate of 1,250,000 shares of common
stock, par value $0.0001 per share (the &#8220;PIPE Shares&#8221;), of the combined company (&#8220;New Semnur&#8221;) following the consummation of the transactions (the &#8220;Business Combination&#8221;) contemplated by the Agreement and Plan of
Merger, dated August&nbsp;30, 2024, as amended on April&nbsp;16, 2025, and July&nbsp;22, 2025 (the &#8220;Merger Agreement&#8221;), by and among the Denali, Semnur, and Denali Merger Sub Inc. The purchase price for the PIPE Shares is $16.00 per
share, for an aggregate purchase price of $20,000,000 (the &#8220;PIPE Financing&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The closing of the PIPE Financing is subject to customary
conditions and is expected to occur immediately following the consummation of the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company also announced that on
August&nbsp;16, 2025, Jaisim Shah informed the Scilex Board of Directors that he would resign as Chief Executive Officer and President of Scilex, effective August&nbsp;17, 2025. Henry Ji, Ph.D., who currently serves as Executive Chairman of Scilex,
was appointed as Scilex&#8217;s new Chief Executive Officer and President and has assumed all of the duties formerly performed by Jaisim Shah. Jaisim Shah will continue to serve on the Board of Directors of Scilex. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jaisim Shah will now dedicate his time on a full-time basis to his continued service as Chief Executive Officer and President of Semnur. In 2013,
Mr.&nbsp;Shah <FONT STYLE="white-space:nowrap">co-founded</FONT> Semnur, and he has served as its CEO and President through the acquisition of Semnur by Scilex in 2019 and continues to serve in this position as of today. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page | 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously announced, Semnur and Denali are parties to a pending business combination (the
&#8220;Business Combination&#8221;), which is expected to close in September 2025. &#8220;As Semnur is in the process of becoming a public company through its business combination with Denali, having a fully dedicated CEO is an important milestone
and would serve to unlock Semnur&#8217;s potential value. Our team and I are proud to continue our leadership in the creation of prescription <FONT STYLE="white-space:nowrap">non-opioid</FONT> therapeutics addressing
<FONT STYLE="white-space:nowrap">non-opioid</FONT> pain management for the millions of acute and chronic pain patients,&#8221; said Jaisim Shah, Chief Executive Officer and President of Semnur. &#8220;Semnur looks to accelerate its mission to
increase access to prescription <FONT STYLE="white-space:nowrap">non-opioid</FONT> therapeutics by further advancing its lead product, <FONT STYLE="white-space:nowrap">SP-102,</FONT> through the final phase of clinical development for the treatment
of LRP/sciatica. We are grateful to all of our investors and partners for supporting us through our successful transition.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Henry Ji, Ph.D.,
Scilex&#8217;s Chairman and newly appointed Chief Executive Officer and President, stated, &#8220;Jaisim has played a prominent role in Scilex&#8217;s rapid commercial growth and product development. We credit him with many important strategic
contributions, particularly in regards to: Scilex&#8217;s acquisition of Semnur in 2019; the launch of ZTlido<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> and making ZTlido the number one prescribed branded <FONT
STYLE="white-space:nowrap">non-opioid</FONT> analgesic by pain specialists, with 1&nbsp;million patients treated since its launch in 2018; <FONT STYLE="white-space:nowrap">in-licensing</FONT> and launch of ELYXYB<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> and Gloperba<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>; and contributions to the completion of the first <FONT STYLE="white-space:nowrap">SP-102</FONT> Phase 3 clinical trial. We
are very appreciative of Jaisim for his work and commitment to Scilex, and we know he will bring tremendous value and leadership skills to Semnur as it is advancing the second Phase 3 clinical trial for the development of <FONT
STYLE="white-space:nowrap">SP-102</FONT> for the treatment of LRP/sciatica.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information on Scilex Holding Company, refer to
www.scilexholding.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information on Semnur Pharmaceuticals, Inc., refer to www.semnurpharma.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information on ZTlido<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> including Full Prescribing Information, refer to www.ztlido.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information on ELYXYB<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, including Full Prescribing Information, refer to www.elyxyb.com.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information on Gloperba<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, including Full Prescribing Information, refer to
www.gloperba.com. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g27011g0821034745760.jpg" ALT="LOGO">
&#8195;


<IMG SRC="g27011g0821034745974.jpg" ALT="LOGO">
<B>&#8195;</B>


<IMG SRC="g27011g0821034746192.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Scilex Holding Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scilex is an innovative revenue-generating company focused on acquiring, developing and commercializing <FONT STYLE="white-space:nowrap">non-opioid</FONT> pain
management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease. Scilex targets indications with high unmet needs and large market opportunities with
<FONT STYLE="white-space:nowrap">non-opioid</FONT> therapies for the treatment of patients with acute and chronic pain and is dedicated to advancing and improving patient outcomes. Scilex&#8217;s commercial
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page | 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
products include: (i)&nbsp;ZTlido<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (lidocaine topical system) 1.8%, a prescription lidocaine topical product approved by the U.S. Food and
Drug Administration (the &#8220;FDA&#8221;) for the relief of neuropathic pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain; (ii)&nbsp;ELYXYB<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, a
potential first-line treatment and the only <FONT STYLE="white-space:nowrap">FDA-approved,</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ready-to-use</FONT></FONT> oral solution for the acute treatment of migraine, with or
without aura, in adults; and (iii)&nbsp;Gloperba<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Scilex has three product candidates: <FONT STYLE="white-space:nowrap">(i)&nbsp;SP-102</FONT> (10 mg, dexamethasone sodium phosphate viscous
gel) (&#8220;SEMDEXA<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>&#8221; or <FONT STYLE="white-space:nowrap">&#8220;SP-102&#8221;),</FONT> which is owned by Semnur and is a novel, viscous gel formulation of a widely used corticosteroid
for epidural injections to treat lumbosacral radicular pain, or sciatica, for which Scilex has completed a Phase 3 study and was granted Fast Track status from the FDA in 2017; (ii) <FONT STYLE="white-space:nowrap">SP-103</FONT> (lidocaine topical
system) 5.4%, <FONT STYLE="white-space:nowrap">(&#8220;SP-103&#8221;),</FONT> a next-generation, triple-strength formulation of ZTlido, for the treatment of acute pain and for which Scilex has recently completed a Phase 2 trial in acute low back
pain. <FONT STYLE="white-space:nowrap">SP-103</FONT> has been granted Fast Track status from the FDA in low back pain; and <FONT STYLE="white-space:nowrap">(iii)&nbsp;SP-104</FONT> (4.5 mg, <FONT STYLE="white-space:nowrap">low-dose</FONT> naltrexone
hydrochloride delayed-release capsules) <FONT STYLE="white-space:nowrap">(&#8220;SP-104&#8221;),</FONT> a novel <FONT STYLE="white-space:nowrap">low-dose</FONT> delayed-release naltrexone hydrochloride being developed for the treatment of
fibromyalgia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scilex is headquartered in Palo Alto, California. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Semnur Pharmaceuticals, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Semnur is a clinical
late-stage specialty pharmaceutical company focused on the development and commercialization of novel <FONT STYLE="white-space:nowrap">non-opioid</FONT> pain therapies. Semnur&#8217;s product candidate, <FONT STYLE="white-space:nowrap">SP-102</FONT>
(SEMDEXA<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>), is the first <FONT STYLE="white-space:nowrap">non-opioid</FONT> novel gel formulation administered epidurally in development for patients with moderate to severe chronic radicular
pain/sciatica. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Semnur Pharmaceuticals, Inc. is headquartered in Palo Alto, California </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Denali Capital Acquisition Corp. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Denali is a blank
check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Information and Where to Find It </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press
release relates to a proposed transaction between Semnur and Denali and does not contain all the information that should be considered concerning the potential Business Combination and is not intended to form the basis of any investment decision or
any other decision in respect of the potential Business Combination. The Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> related to the Business Combination (the &#8220;Registration Statement&#8221;) has been declared
effective by the Securities and Exchange Commission (&#8220;SEC&#8221;), which includes the related proxy/prospectus of Denali (the &#8220;Proxy Statement/Prospectus&#8221;). Denali is mailing a definitive Proxy Statement/Prospectus and other
relevant documents, including a proxy card, to the holders of record of Denali&#8217;s ordinary shares at the record date, August&nbsp;12, 2025. This </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page | 3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
communication is not a substitute for the Registration Statement, the definitive Proxy Statement/Prospectus or any other document that Denali will send to its shareholders in connection with the
Business Combination. <B>Investors and security holders of Denali are urged to read these materials (including any amendments or supplements thereto) and any other relevant documents in connection with the transaction that Denali files with the SEC
when, and if, they become available because they will contain important information about Denali, Semnur and the proposed transactions.</B>&nbsp;The Proxy Statement/Prospectus and other relevant materials in connection with the transaction (when and
if they become available), and any other documents filed by Denali with the SEC, may be obtained free of charge at the SEC&#8217;s website (www.sec.gov). The documents filed by Denali with the SEC also may be obtained free of charge upon written
request to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Denali Capital Acquisition Corp. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">437 Madison
Avenue, 27th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participants in
the Solicitation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Denali and its directors and executive officers may be deemed participants in the solicitation of proxies from Denali&#8217;s
shareholders with respect to the proposed Business Combination. Information about Denali&#8217;s directors and executive officers and a description of their interests in Denali is included in the Proxy Statement/Prospectus for the proposed
transaction and is available at the SEC&#8217;s website (www.sec.gov). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Semnur and its directors and executive officers may also be deemed to be
participants in the solicitation of proxies from the shareholders of Denali in connection with the proposed Business Combination. Information about Semnur&#8217;s directors and executive officers and information regarding their interests in the
proposed transaction is included in the Proxy Statement/Prospectus for the proposed transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential
transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of Denali, the combined company or Semnur, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities
Act of 1933, as amended. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical
facts and may be accompanied by words that convey projected future events or outcomes, such as <I>&#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221;
&#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;seem,&#8221; &#8220;seek,&#8221; &#8220;future,&#8221; &#8220;outlook&#8221;</I> or
variations of such words or by expressions of similar meaning. These forward-looking </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page | 4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statements include, but are not limited to, statements regarding future events, the Business Combination between Semnur and Denali, the estimated or anticipated future results and benefits of the
combined company following the Business Combination, including the likelihood and ability of the parties to successfully consummate the Business Combination, future opportunities for the combined company, and other statements that are not historical
facts. These statements are based on the current expectations of management of the Company, Semnur and Denali and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not
intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from
assumptions. Many actual events and circumstances are beyond the control of the Company, Semnur and Denali. These statements are subject to a number of risks and uncertainties regarding the Company&#8217;s, Semnur&#8217;s and Denali&#8217;s
businesses and the Business Combination, and actual results may differ materially. These risks and uncertainties include, but are not limited to, general economic, political and business conditions; the inability of the parties to consummate the
private placement; the inability of the parties to consummate the Business Combination or the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement for the Business Combination; the
outcome of any legal proceedings that may be instituted against the parties following the announcement of the Business Combination; the receipt of an unsolicited offer from another party for an alternative business transaction that could interfere
with the Business Combination; the risk that the approval of the shareholders of Denali for the potential transaction is not obtained; failure to realize the anticipated benefits of the Business Combination, including as a result of a delay in
consummating the potential transaction or difficulty in integrating the businesses of Semnur or Denali; the risk that the Business Combination disrupts current plans and operations as a result of the announcement and consummation of the Business
Combination; the ability of the combined company to develop and successfully market <FONT STYLE="white-space:nowrap">SP-102</FONT> or other products; the ability of the combined company to grow and manage growth profitably and retain its key
employees; the amount of redemption requests made by Denali&#8217;s shareholders; the inability to obtain or maintain the listing or trading of the post-acquisition company&#8217;s securities on The Nasdaq Stock Market LLC or the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> markets, as applicable, following the Business Combination; and costs related to the Business Combination. There may be additional risks that Semnur and the
Company presently do not know or that Semnur or the Company currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements provide
Semnur&#8217;s, the Company&#8217;s and Denali&#8217;s expectations, plans or forecasts of future events and views as of the date of the communication. Semnur and the Company anticipate that subsequent events and developments will cause such
assessments to change. However, while Semnur and the Company may elect to update these forward-looking statements at some point in the future, each of Semnur and the Company specifically disclaim any obligation to do so. These forward-looking
statements should not be relied upon as representing Semnur&#8217;s or the Company&#8217;s assessments as of any date subsequent to the date of this communication. Accordingly, investors are cautioned not to place undue reliance on these
forward-looking statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page | 5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors and Media </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scilex Holding Company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">960 San Antonio Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Palo Alto, CA 94303 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Office: (650) <FONT STYLE="white-space:nowrap">516-4310</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: investorrelations@scilexholding.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Website:
www.scilexholding.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"># # # </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SEMDEXA<SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP> <FONT STYLE="white-space:nowrap">(SP-102)</FONT> is a trademark owned by Semnur Pharmaceuticals, Inc., a majority-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA
is planned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ZTlido<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> is a registered trademark owned by Scilex Pharmaceuticals Inc., a
wholly-owned subsidiary of Scilex Holding Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gloperba<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> is the subject of an exclusive,
transferable license to use the registered trademark by Scilex Holding Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ELYXYB<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> is a
registered trademark owned by Scilex Holding Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scilex Bio<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> is a trademark owned by
Scilex Holding Company, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All other trademarks are the property of their respective owners. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><SUP STYLE="font-size:75%; vertical-align:top">&copy;</SUP> 2025 Scilex Holding Company All Rights Reserved. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page | 6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>sclxw-20250816.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 8/21/2025 9:27:35 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:sclxw="http://imetrix.edgar-online.com/20250816"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://imetrix.edgar-online.com/20250816"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" namespace="http://fasb.org/us-types/2025" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sclxw-20250816_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sclxw-20250816_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sclxw-20250816_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="sclxw_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="sclxw_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="sclxw_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" name="WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>sclxw-20250816_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 8/21/2025 9:27:38 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="sclxw-20250816.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="sclxw_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="sclxw_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_CommonStockParValue0.0001PerShareMember" xlink:type="locator" xlink:label="sclxw_CommonStockParValue0.0001PerShareMember" />
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" xlink:type="locator" xlink:label="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="sclxw_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="sclxw_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sclxw_CommonStockParValue0.0001PerShareMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="32.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="33.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="51.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>sclxw-20250816_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 8/21/2025 9:27:35 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="sclxw_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sclxw_DocumentAndEntityInformationTable" xlink:to="sclxw_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="sclxw_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="sclxw_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="sclxw_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="sclxw_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="sclxw_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="sclxw_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_CommonStockParValue0.0001PerShareMember" xlink:type="locator" xlink:label="sclxw_CommonStockParValue0.0001PerShareMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sclxw_CommonStockParValue0.0001PerShareMember" xlink:to="sclxw_CommonStockParValue0.0001PerShareMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="sclxw_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Value 0.0001 Per Share [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="sclxw_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Par Value 0.0001 Per Share [Member]</link:label>
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" xlink:type="locator" xlink:label="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" xlink:to="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrants To Purchase Common Stock At An Exercise Price Of 402.50 Per Share [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants To Purchase Common Stock At An Exercise Price Of 402.50 Per Share [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>sclxw-20250816_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 8/21/2025 9:27:36 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="sclxw-20250816.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="sclxw_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="sclxw_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="sclxw_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationTable" xlink:to="sclxw_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_CommonStockParValue0.0001PerShareMember" xlink:type="locator" xlink:label="sclxw_CommonStockParValue0.0001PerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sclxw_CommonStockParValue0.0001PerShareMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="sclxw-20250816.xsd#sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" xlink:type="locator" xlink:label="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sclxw_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g27011g0821034745545.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g27011g0821034745545.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% 1H# 2(  A$! Q$!_\0
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M.EM?7SG&=L<:_>D;T%<)"/'?C>/[7'=+HFF2<Q*K%7<>N1\Q^N0/2LK7Y_\
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MNN\5?\DUN?\ KUC_ )K7(_&#_D(Z7_UR?^8KK_%7_)-;G_KUC_FM &/\(?\
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MQ_VOY_7KZ'7FGC_P,TI?7-'0K<)\\\*<%N^]??U'X]>H!Z4S*BEF("@9))X
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MHN1S5.[UJ\L/$EP&5I=/C5/- ',>0/F'X_SH Z*:UM[@@SP12D="Z!L?G4@
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MV]TV\<2S6A&)@,;U/3(]>GYT :']F6'_ #XVW_?I?\*?'8VD+AXK6!''1EC
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M&P1JV_RS+M^79U\S\O\ /:NCCMRD2(T\KLJ@%B>6]Z )Z*** "BBB@ HHHH
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.WE>7M]\YSFM6BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g27011g0821034745760.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g27011g0821034745760.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ? !\# 2(  A$! Q$!_\0
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BUGZ+I@T?2(+ 2^:(AC?MQG\*T*SKSYZDI7NKE4X\L4C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g27011g0821034745974.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g27011g0821034745974.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ; !L# 2(  A$! Q$!_\0
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MX;6'7]:O[E/M#\21W!.QCR 0.E>@>&/CM#%X;LH]84S:@B%99,XW8)P?KC%
M'"_#7_DN\?\ U]W/\GIGB0 _M 3 C/\ Q-!_.G_#7_DN\?\ U]W/\GIGB3_D
LX";_ +"@_G0!Z]^T!_R39_\ KYC_ )U\J5]5_'__ ))M)_U\Q_SKY4H _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g27011g0821034746192.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g27011g0821034746192.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  7 !\# 2(  A$! Q$!_\0
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M52.X- '2:3\))?#NH/=:'XFN+8XV0_:+.*X>"/).Q&?H.>V,]ZWO^$<\7_\
M0^2_^"JW_P *** #_A'/%_\ T/DO_@JM_P#"N=O?@Q;ZUJ;WFNZ]<W:RX,\5
3M;QVHF89VL^S@D9ZXS110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 16, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sclxw_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Scilex Holding Co<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001820190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 16,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">92-1062542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">960 San Antonio Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">516-4310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sclxw_CommonStockParValue0.0001PerShareMember', window );">Common Stock Par Value 0.0001 Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sclxw_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SCLX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember', window );">Warrants To Purchase Common Stock At An Exercise Price Of 402.50 Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sclxw_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Warrants to purchase common stock at an exercise price of $402.50 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SCLXW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sclxw_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sclxw_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sclxw_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sclxw_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sclxw_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d27011d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d27011d8k.htm">d27011d8k.htm</File>
    <File>sclxw-20250816.xsd</File>
    <File>sclxw-20250816_def.xml</File>
    <File>sclxw-20250816_lab.xml</File>
    <File>sclxw-20250816_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d27011d8k.htm": {
   "nsprefix": "sclxw",
   "nsuri": "http://imetrix.edgar-online.com/20250816",
   "dts": {
    "inline": {
     "local": [
      "d27011d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "sclxw-20250816.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "sclxw-20250816_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "sclxw-20250816_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sclxw-20250816_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 30,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 26
   },
   "report": {
    "R1": {
     "role": "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-08-16_to_2025-08-16",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d27011d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-08-16_to_2025-08-16",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d27011d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "sclxw_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imetrix.edgar-online.com/20250816",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Par Value 0.0001 Per Share [Member]",
        "terseLabel": "Common Stock Par Value 0.0001 Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "sclxw_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://imetrix.edgar-online.com/20250816",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "sclxw_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://imetrix.edgar-online.com/20250816",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "sclxw_WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://imetrix.edgar-online.com/20250816",
     "localname": "WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants To Purchase Common Stock At An Exercise Price Of 402.50 Per Share [Member]",
        "terseLabel": "Warrants To Purchase Common Stock At An Exercise Price Of 402.50 Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imetrix.edgar-online.com//20250816/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-25-184619-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-184619-xbrl.zip
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M>7Q%PO44*_FB2.L\,G4+]&B/+,D51 -/M$K,-'+I@!6WN&?@EP\J E;Y)6@
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M1'&*)$G31C)R@ 4>GR2X-!I?F8K0Q06H:_?N8E"[(&/P-@*L*\*@%T;-,C4
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MPJ\MU+,T81@+5 'L UA$1\[H5V:!LL+1U84%U0!'CP<>3S*3_X)SN;/]4UA
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M6BHLHR^:;;7:7=MB]HB_[(K1F)B3D>_QFUT+-<'KYJ_VR]R'0*3CJ9VR"':
MWPM/HB =YKW!\2M)O!Y]Q(L^3B!V=UM<31;8YN0*OZ2+:1B4Q+9KYQ?XHA;B
M#4FRW=G?;;4[+=-F 4B0VO_H3P4 \'HWZ3P@GT0TK/IKY<6^R?3%]O?T147Z
MXM6;C$N(P))!Q@,6?[O27J'?Q]+WS>]ZR7<75\<G5\VCB[.SP\OKDSWSP_S3
M*!^=L_T>51LT]=)[;0WF7MM 2" F#*F_KO\UX-RB10$F@MXY'Y.>?OLG0J@S
MFO^^V\$';]9A4IK:/'7.-:! X!Z86V!&++TU(N["@GISFGHZK3;R S7#%S^T
MZ7_[E3NHZNE0$!.:']_TDO6#\PFKRM>=W:U]_8\U&C+_8#'"<I8L#W_L!O:K
M)/G2W-XI<OOKAXO18])%8R[^'3,>Z,0U.16[91!=SAR>9E>0H64Z<IY@U0"B
M^NU*]WF("OEE9>X9 A(KT8UJ[K,)8'8MH$TIAJ CWZ[XW9UVI^.K^]W=3FN8
MP327I)&O6",;MZ?*$$%%(IUS^:\YE4Y[\UD.Y8BJ$"YA8UQ"*OE&UK',L$U/
M"(>![1(E56V0ZXH^".CU3.GO5=NO:+.!1GV0P+";X(RKP9_OKL[66@X?P7]1
M;[A,[:#'M6'K57K!%/@F;8J=[S;%"Y9$S CZJB.Y/OWY_/#FMZN3ZQ>_WE#X
MG)=IK9LG#4],U_I##B1V=C<V&_K% 5U_B?C+6CY^L)R^$^47?!C]=33L 435
M$-@32'\R1@>0^-O-/(!#(MA/&Z?+"[IG'(82WRYB/I?9D'(.OJ0-N5EO0C*=
M5EF115KO=-$>7-ZN[-38E:]WK%U9LC)>1MTX6F]CH0%Y?71Z=O*G^'!Q=GQZ
M_K,XNOAX>7C^OZ[9^"BUC 14HY?IT=>AF%<.WDWW9M6JT(3Y[N+FYN+C7KNU
ML[6LN5ZGJ1\^(X&WGJZ+#RI*IN*7H.8P7@I3YW*D*G#U>1:+&?Z5[/$&$YW/
MMLF:C[?S+/^0H_%^_@WW"@.+;8KG5&/8P&E/6^G"&.C?<*#G=8U1]F:]%_M3
M^!U<E?#@_P%02P,$%     @ $3@56[NW7+8M'   &'(  !    !D,C<P,3%D
M97@Y.3$N:'1M[5UM4QLYMOY.E?^#BMG92JIL!T/("Q#J.F 2MDB@@-U,[C>Y
M6[8UM%N>?H%XZ_[X^YPCJ;O=MK$)(;M3-;M5D]!T2T?GY3DO.E(./EY_.CL\
M^-CK'A\V-@ZN3Z_/>H>]WUIOW[8[!R_LCWC^PKT@#MZ?'W\5[S\<G9^=7[[;
M_/+Q]+JW*:ZNOY[UWFU&.E:MD=+#4;;WV21C&6T>BL8&OC]2<::2PX/CTW_Y
ME^]TF(WVWK1W=;PI9*2',090@VR3I[GPKXUE,M1Q*S.3O:U)MB_<SWV3969L
M'PU,G+52_6^UURE_'LBQCJ9[UWJL4O%9W8E+,Y:8J7MV^N'SN\V$B-P\/'A_
MV/LVTGV="5JQ.'CQ_O#@Q<5AA8#*Z-L8O4;/'#F;AW^/^^EDGT;AI5]WWY_U
MQ%'O[.SJHGMT^OG#N\VM3?[YHGM\['_^<GI\_?'=9F=KZ]=-\?[\\KAWR<\=
M$?9)"UP_ZUY<]?;\7^Y=;)TSQ>(#EL8FTR>(Q,M#]Y=C3\AKT %.7!^7O_F7
M^]JNM239OS@[P/9;_QS_N:Q,Y9<TD4/5ZB=*WK1TG.I0[<E;HT/QL"4=+B:.
MY\-O3C]]$%>71^\VA]NOMSJ=X=:;[<[6SLO7+W=W7^ZV?Y\,B2?7[S;/SC^<
M;[*BEPNI#VGEZJ4[_QY48O/PZ327=/7D_%*<?OK4.S[M7O?$9>^LU[WJK=99
ML9*46:U==PV=[UE#-Q_F:6:GV^XTQ?;6]JY?0E5?\ =9SA*.SJSK,2R]"G2D
MOHF/)@IU/!1'9CR1\50\^RS34/ZQ)ZZ.SGY[+KIQ;/(XP->G62H^R=]-HK-I
MZ_PN5J&XROO07RV3:5-<J7&<)^)B) %_@<HS'<@H;8K3.&@W-I[]_9<WV]M;
M^_8M_J&S_[PI9!R*8Q4#!<61G.A,1J(;_)'K5&?:Q" JF;3%1WFK1(\L%W/J
M.#-"BHL\"48R5:([3)0:PZ[%G<Y&&! SWJHT,PDXD.#-OVUOB4\ZBFB\BT3?
MRDR)BP@D\D<R$W_KO&IO;8F)2D0*ZA43]0\)&L;B:B1'6!NSBJCNO-Y/ 6'G
M_,Y%HLA\XZPIOF "T5=82XAU9Z S,XT-QQ-,+,5)CC=(#N*]3'6*WXM+K#B,
MIJ(;WDJP6!R<G'^^+KS$2&>JE4Y Z%YL[A()&[NZ:'6VM@]>T'N'/((:YI'$
M6C'(9)*86_"/*(,PQRH)-/CZ;\F<)%YD(R6N@3L9K]P,Q%D^[IM4!@D^NY2@
M'(-!A%+'XMG9Y<7S%UBX)$$6[F&)B?PPI;SHGIT3,)TWQ1'0!6;_^;0KF/.=
M?6$MB&DA<OB/67L2SSZ<G;_OB<^]+U=?3B][ST6+:5^F[%XM"P%#+85E56/#
M_=*][)6V9B&DPU#*&+S/-/0T4;<JSE5KJ&*5X!%F"]QL Q/D*52#](&4/,$O
MFR+$!Y&9T(LDNJ B.GJV4BEB$[?P.3R(5XP)"1 <A9]A24,QPCR ^7HER*I*
M((,\LSH?C!(3ZZ"QP0/0DUCE^%;YM=RZ]V02:C-6F>R;2 <BU*F"*3:AD:&<
MXA4+&;"!$<Q+8^*QQPW#N)&NB1OB$;!1?&O?*Z0W(C!1LV R<6#2V) %FOC/
MYX&F&,H#CIX#'*N48X<Z$X<Z$X\Z398"Q!(H%:8D! @V&&% BR*L)429 P9Z
M.U6!(<QA6G9$@)"3. 590E4*R3IE<K*%M3X,4IYUML28=?*;A'PQEXDQM0EU
M/A:3D4DG(UK(K4X#DZ=BJ*+GI8QZGXY[OW4/KOZYP!N_WOUU7]RJA*7;XJ!W
MC\.&O__2V=V!]\57AQ7[6TFWGY3)+Q3#K:.QL5#3 6D%HK5%+7+XX6@&Q4ES
MB9DA2")E7I&L&A3:@U\*UC^6O==)4C YQ.,A<1ZKZ#2W=[>:6_!8[*U8?0@T
M3-S8P#C!31, D BX@ER)OVW!M6UU*L[M&<WI=?OTHD<N#J.4MH7AZ!4,V==D
MK$$-*VF)L_8(/D21N2.TLE_&:3X>6[_C1LL2&</1T*-TAH3W>8I9TI0@&?/Q
M1\6X&"E38Y@-.=3^E$<J_3V[X$C&K.B?5#)4"327WZV&6CM;[!I> C7 7WP9
M6@CNPBPC^TKGE?4>%EC^D4=3YU6VO5>I4&QGFH>#)E%(WTN(PG+"0H_'N!G8
M<J,@@K)(=TV X$4.RF#U7H<K4A((',IP!?*FITV+.U4UJ8T$(0"42&=8;^94
MX 2,CP/(SZ_EZ:V#UAM$)B6E<3HR2PHM%7[B=Q6P!<%S8B)XC,8&X:"VFD0,
MQ7OJVP2O6;LQ00!WHN%$X6 R%4W7T,Y%2OAS6. #$;@\4W><9-!512ZUM!*<
M CX@_3%_HUR@*MX;>&A:W+%.P!B3I'9$O'%G\B@4%+@.8S*(HY%6 ]'[IA %
MD'\_'PR@,<EL?$M#V:&;0@T&&))>G:'MM:4-P;J*$8W^ UI_,6H?MYMP;22]
M),$X$$:J$L =S5S.>322&LX_KDS3V+@C:YU,#%PT%H<?:D%X#$:N1SS]Q-B:
M0O T%IRL$WR([Q3'18BY0!V,RG$3MESA<GN&Y>RF"9LT CW2.5X480HKTSSS
MBW59I7K2('J.4'A,^'.;EH@191Z4A'!.,D!.TN(?^SXGH1?\TD)>& '(@Q2%
MP:X-6(-&='8@RD])VVH)$[72M0>F-8 =@&8?EE3Q$QPF83++62\HOIS+R"")
MQ.3#$4M$5D+#@D"2L#,7S92^=>&W77M:RE637,&6B7%C2)8H![L.):AP-UE2
M.I@3J*A*],UL">+IZW^^!':![$#\G^CX!5#=X?CT7TBK7,F2RU94Z9F(-)M&
M:E97U7B.(GI4J6WU%4Q)[<GH3DY3J@^]F)#F?[P45Z?_B_7M;/IQN:2Z]\M;
M_E^M(NBH/NI]ONY=_M<550^[4 MD?!K1<%3)?(JTIN+Q*?A"8,: 8[,.A"+D
ME?K>^P2E]V$?762@]P5)39<[U-P@^596W2LU00S5AZ5:?'9#@G!'(C[4<9F0
MI*S<?60;8TY)$4OT*<GS8: W+#*[A91S5N0C'V1;=A2"FFF!0R%;K$XY>QI/
M3))1H P64R0<4QX&OEE796T0*\KC",%M)?1D-S Q&92!4B .>-OB'$O*E!PS
MZT\MUT&Q98K';(.7(B5#E:0C/?'K#RA9<" !J:9!HB?\\W?DX!@/O^%T%JL,
M0PQ'L<X:&=GJ?-X'ABZ_3!=F\?:K"1:$3]*FSZU2J6O%K0<#^TQ.+B)C;JQ"
M!X&*J$R@;,JOL6!RB::QH6-B+>4R 2L8I3<_DK^ \D&>T".7,G/\"")(QK[\
MT5RWOM8LYRA]R #J'2$%IE50PN73[VK"/9=T-C9<UID66><7Q2HY)#[!)IAQ
M-AXAG?2YH(UL"2UBJ"@/G.83LA-:69X6I-%':<Y<Y=$HS6(GU?8"?^HHMA[O
M-3;JU5(?W=F"TAWA9!'7K:5\33@* HVF5SVGOQ0'(#F<4AQ 4@9@D1@2$UGD
MFZ4CH6IKI;P&&9@[+N 4*E*5)HL*:HM4 T'1V,+:F!"P!*PT(S$.J61&T)+H
M?LYY2=,"/9=3L5S00GE9$I+F[]7I6AR=N)ADGQ4JDO J(_KM_UY'.C0/K;%@
M=E=BX=6.Y0VID1V+)XAS]A!4['&&V:<8&-I$R;*U&PCV(08*N(J&$&! ULE8
ME,([45DS!1Q9=G9J=3('5M: */S45/UB0[8<L%QYL[_:E*'2\%HJ)M M20HK
MK.R=??WMZWMF9;&T[V#F!^B+2OKR^V6R7P2>A0+YFA$YW4A54]6!3M+LH3L%
MBXN&I.'PM$ C$,A&F2C&J5N&.&=DA#T4_=Z9Y*8H4&M;4P.5/BUDAZW$#64;
ME&9R)3/AI#LAKQ52O=#6I%@,I?--;_ NK]C'3!33<W!08/GW%D#74=U95BTM
M'!80_K. ]024C!%!NPS?128>UNI;&4U S  F3.[V[NZNG?);(_M2&S)[^GK&
M4H+OJ?"79 NFFE^=\)LET4^:+R^C^M%("^R*<A81;_U=.%RE!Z?E5#4&_#NC
M6?_#2Z\@XW<MO?E]:U?1]-NTSVNG9/0_HZR/A_.'K]Y:[-#-O-!8']&+LSS[
M7?#9RNZ1UZ^V%G2/ !,[;W?W5W[]]O7+1;TG[P_= +15NVJ05YVWVPL;6)8J
MS)L?M#G=[9L\6X*_JW;(7_T(&GR]*OWOW'-N;'S_IK/XOCWGMA='!M:JC$H9
M7&'@((ICS)%&FI3'^!(CTVZKC0+Q-HGC!H\-)U9YK+DT0Q]]5Y9N,U)73IY?
M<1'<VEWCY>N'=,-*%TDE"N+?CJG-@WYR R(%S" _E;;KB44I56<=?]XJY?9?
M5<K'X$9CH[!&ZYO4GGBFGUN!/CK0>4;?!U!?*M--."9/IVFFQL]%I_WFUR8G
MYY5JS_SK/OV6W,-4[O7^LWW5%B?&A*3ZC8WC)!^*;H@T7W/F[>NDOBQP<MRM
M;$E;&TQ41!4&&"#C"HQF5!A;FAH*ZC$?V^3$I&3#$^1; ;^-!%;+2GU5\D81
M&S->;2%[B8>1HJTH*E'2F/M@J^?KXZ,H";D5Y4U._%H1LZW %4($6J6)H^EJ
MU 9_6I[%19%KY5<K7P UX13*VH*C<:/ZP0UUEJ4FRF=ZT"SXS:#C6 \34@E7
M&# )8B+\A?RMA" HI@(0YE&6VFP9;/9\_A$16YE9T^#,S4C#6X9V!?@^K>3@
M$A)I#8DVVF0.2"2!B8*1_:OS0- JOUYP?#*:1O*;3JTG0,R91X)'&$1V7]\O
M[R>$OJ<TE]U!]ZV-7$K+1HE2A2T&X(2F;HIT;[6.%&#RF':BQL9_:S]1"0&V
M?XVV#LO]'48&Q&(J:E8[HQ@LJ#O3:8Z$:H?4C\#Q6$"UW  PHA+$$+9A24UT
M2*@#;:"VAZ(01(8BHDJO9E+T:I(N-6F!OCQAFT$LO179ND(25TI]!27-\M!V
MK-!>.^R/*[(G$E9PG<C@AJNN6,L@,6/68^"'J\"]MD"W9AUJI]"'.>AO;'A7
ML=M^^>L:)?IG54'MS D*@E#?LB(0)@W/X'<B# ,VQD-@2TTLUOTU[PM3B]!L
M(6L3%=C6AGD>;[OB%'W.(T7F3O3!6MMBV7XH_VBZOE+Q X3E9W3NB5:QAC7K
M&7M^6<CO97N7#7KE$)BV%9K"'XA81F#L-][;&TW#Q 2CR"2P!V #5_!;<-2\
M113(29K#JZZA7#.Z\'*1+I!1/IS8.DDE\6*6]KZB0-PE4Q7 K^H03%OW(90I
M1Q-/7X4K<\01_/(?N4Q\JZNXD)$1W2B#MA\!,D%M["E:5F?ZP:GS?;V^"TYS
M_/#\N=CQED7]N+%![86 !\HTW!9%-A63&1H7I=/U:G,]D2X09DTM7++O6Z25
M[;FM[[JG7GN'LVB3??9X)_N\2?Q\P-;$_#HM@^HN4[I G[77NT:[FU;?=)W-
MK<<FM-O0W,$#^E619!>.TP)P95_VJ<M']ZK^VL9ZGZW^$ LI3'7EH9R?8*Z.
M!C;7?B1CN,U@I.#+2FOD7KTBSLZ3B;'[\ZY+D5M/QJXUV/8_JV_!2,9#1>W
MJ<JJVZ_^%=\]2Q5:DPQE7!@SXBP-6A%X+6]](3?AB\O^+>K23NC4 =>8?@[D
MGA;;U)6B,Z/4EQ'9!*SC1%./3/8S9'G-'734!=/8\'X5?U)^X;JAD"09/O=0
MMHK#P69W%.\LZ*;"7T-#R;?)>.^48[0H<BWUY8*Y\34=<2]1W[;_PG4G'(+'
M@8)5N?W%,M5>U&[E(WV:CEH7>&,<A'-%@#ZW'904,U*+ /=Q,#Z%\"@V>4RH
MK6DJ#/>I%(^Y.8#\3N;3R_L)L:WBEVI8UD"NJ#O"AANQ."&"5ON!5A'462F$
M?LMYX>*K59;%4U?.U[@8%2NDW!:Y3=DR[.HZ5RK($UMN);;VG$GRL377-E1F
M@4=SG6ZVA)7Z^@Y3#_7Y-GV!_S(K<Y:$4Y69=G=ZK:3ZQ47Q0=GZ7L+.6.K(
M8DBH!IH*Q%C#\B%L\8#$:W7\EHP/"4\^YA:LRKZ0M/1R5;OI.4^;M<IV"R.G
M,*Z)N#B]Q#X?3R&39.K/?LC,<8'?MT' 3%_VMN_+9@/\DY>!=_XJ S^N#$SQ
M:1Z[#1(/9Y+/X\$U48;J?>EB*V^ZJ'<=8^ S*07<.2NP<.PLC)M$4A4S]E"7
M#RNU-P, (Q ZMH40ZUJY)W;)80TXO)GFN=1BS+1J5I5.W!PQ <]+U4L:.*7]
M( @*N)N*9Q53I=,9U,#"1BQ<)UZD[(^T.)69Y_;@3['<>>M?LIP9;U?ES8!Z
M8<O7 (.-C;N1BFVGC1ZP)*:V3U<)>0NDDOV(4M) (D.QORT.*I!S+-O6JNY1
M5J*]F:YE7[BL^^2T3=&"!0'R1.O 8<F/DL5K\.,9+=B6_O5@\7K=6=!Y14N9
M@URJ*[2MY&43A-!@PO2)-Q1#4NV3&CM'O#7H<-5Y'X;>.]5'F*A %3>J!.VA
MN7UNO?%ZD]I#/BLFSB?$#2@N8@#R(G_DT&EN&WSJPL$:$?]30O[ARYW7XA/R
MLY3//?&&-GS7:_#O)#)4PGW:Z>FO7TURTQ2?OPK ^?;VD^>$=-Z=^T0ULAF&
MB,8&ZPKM<$,(MC?ZI^59#"P@(RS.+=$35?3F&MN;FWH5#NG\8^A:78LEV%Z]
MZ@JXF]Y\XYUQJD[.AC3N$*-':388'Q"[P*B H<70?[H$S@K+7;D@AA"LI]RC
MM*&X3CC6!SEV:65DZ&+0T"_X'A2L[@+1*B#C"L;Y#80"P-='GB>O)%:V.-95
M"X:X4C<R^H%J+0]4$7ZAJA:E\U[B-QZL([5BVEHZ4G6<MJ/;)8]U1>% 96%&
M^SC=J0[U<ZH(*S/)SR9N50&KV%?^"?U095%!^)I"$=/:!"LM4^-D3N7<2TTN
M"KAW9)Z-3.(+/G4THC@C+9-7D]R7OL\;.E2:#V1RQ<)'W'SNU;5!IHK.@M E
M$G.T5M[JYU/?$5U0,BABN(6']S&F/T09F\01PL$K62LO2T;*ER_2'&EV973>
M_G+,I*%^QR_24#N-CEU>SE\QD4V ^@S]B1W^SE=A\CB2=[0'/DFT26P87LDW
M\.B/G(J>/E.ATZ!)?<T8@A=NJ5U$6UM\-HYM]%[YJ5U_GT+^D$N""IDNHK:Q
MDNXXE:B4$L9*9;Y*1!&93EST[R1>EC,0N%A%Z+S=V:E>./#T!6:Z),LD=\"D
MUIDQ?,"C@)3T/V:-OE0S<*1%CK2T),U>$A/?FH@Z&75Z8[&6SE$F%"/;BNG)
M\@$HG:N/1\_(SD 20-WN\PPD-4#9 S <P,C FH>V(?N=X1,Z]#G,\Q;9!G3@
M=WNB<I!G.16/;WT2Z+ONFE;](.F#4]]$T*>>HUM5G+ESCS%K_1$E:/5G\"&:
MTJ3Z<W]XL?Z<NE'(MY9?%.=&;:%R;@(^)EI_:DND<P0N>CB)9#SWC$Y*S8]:
M@.'<= @0%CR[J3^SC*\_!?=)$=S3@Q>GAUQ>O96)=KV?'A>L4 T?]\;"^1BF
M_[TKY9/1TR$)2N52-:>J?_*:V<N_:F:/JYE5H,7!61,>N(28"&IDZ^?-*@R5
M\>$,=C27%]F7;G;8;SPNA+:RYHV^P":H-C60\7=]%:N!+CP4%_YF X+92U$6
MT5.M5_,A1'T#7!NY;DQ$T3JB\IJ/>LJ3[>5Y5&Z*<=>MJ'LF<BN8;<3VL6^=
M]&:EKK0V['OCKKF-OJQLYKM+2MPQ^A)'*DWM;K'%F:O%^U*>"H>)Y1'M+*=F
M5WO'"%WLM0QR:E1RQW?H-CKA,7(;*-T6.YZI;5FLS$UGKLM-*GN&7J:6=6-\
MS_3U77LL<<#=7N2WK@P?PY-BF$MN-5)\S1W=H)(0X:ZGUX> '+%6JL*5J'L@
MB/_T!E;1=TK3%EW+"^=/N75")T$^QI=\V20M(]24>T&G.<X>8Z&II@S9GAZG
MN6WS&A4YZ5WH R6/C0V^Z&5BBY7B$Q=PUYBNKZ;&U3WY+*:)5HM[B5I5[BV2
MQ=G:P;+@9C:5]+/YS+19SU3+V<L22F6?V==N%UL:JXAEAL<+"H8<^WQU-IKZ
MA2TC>242V@X\L!R\-&,=-)$70?3<3,,(5>Z?^]N<]MW>[7)DF043RK!K%^L]
M=(C%0.R AV^2 B($15[$^M,4;K>2HD!&H5E=<@$D93I#;4-:Y2M98.^XF,72
M9KL31'GQH,>]1:3MVW6[X-.3%4%_(G^=(-3(T>"B7.TS34A^*.FG&9[,.@)_
M@TD5[982PJV/>I*Y_#2/7=)'@%*8(WYCN4033HNKRB*P(K8@5JC"W%Z(Y2)7
M5C"<LCWAJVB"QMJO>3W^5E2WEB5%I:+.4FR]UVHVI-Z^9(^(0>HHMRT4B(0B
MA!)%7[AWRC4/O-+#,MI:D[3Y)S<A<DFXO+%LKE.A2B664" F=TD1WX9)^5FU
M&:6X9P!?61XLXMY"ZPAUFN03K,S[2TH'W&;/Q'7=IO7US.F6._*^]"JVQL:<
M9&M&/1?20!JN,<P66ZIAB#OJ]<!S\X6%^^,S:Q-"=TNX5)."!W_7!,:!4LB^
M<]:)LCMS8.:-FC8VZ*Y#,U7*SS,&OS+;#Q JZ]&$VQ)*;>FBV&DJW$-5P^MP
M2-?CL1)S@Q)AN>LP%'0K U_%EY!.A95;^?BH2_6.BF#6/\U4H6+>#K/WXXHK
MNHP2_I<Y?W9VY'%UC3/Y*^5D;E72PF"M@%BDDMJY$RONU%9@)A.@$M76FVM$
MO?XRAI1#^)6=,>PG$U54%-RY"G*O[#G9E&9W55FS64\H&[6MXZ%AA.';$YA+
MY5>.:?Z;\B8]5V5@[ZO'WG57@9.+\78[N.;SR53*B G?4-N<VR@N"]/+PU*^
MW:T\1')/_.IB5W\7=AG5+ AU%H0V,\%XTT&-O6E7!3*U^#I;G*%!;K6Z2_T]
M;;1!Z^Y.=>9:]D"TZUO>Q86,!9:[#K*\GY+E47Y0SE-I1$W=;CNSFTH/'(="
M75QZ8ES8T!8?S1UUI7([4Z26$4 :I2(71>:3T$4L*[(%$$J! 5^O4XC1EE"$
MDO;BDR43<N\S55SYHBZ=!I'48[NSWD>Z[;KI#.EJ:I9D+C/9LFNZF\TT>'^;
M3TTX[>="Y6R$.ZORI794V"F+5CMF3$4ZSEA+B>NT+O)N$' ?U3":-JM7+E&C
ML.2C:LJ239D&A994?\[M$O@^9ILPTGW1]YG(G[QPM/M7X>B1]?@C E1$#7L_
MI?P^V_[TB:Z_?>J>B:57(3SDW])X^+1O7VV)*R01W3@SL39X+,.G7FJU';\K
MWK[<V=IY\G7:R]#VQ+-7NUMK'(?:[;QJO=SI;)4[L$]\?TR/^F/W"@3E<(G\
M]/_,73[TY+T*7VR+Q-Z2RX^>>OXZA/XBZ/]/WJ!1.;SSH"O,*L=WUCAE9W.B
MYUZM^#@&)0F*HNRY$[%+KGF2R_\-B/)ZY#J2P%5SZT.BD2CAQ5B.^;(31'>^
ME?SDN-O8T'P/8!ROV&?](4Q__+U0-C,>^J--BUAIN5%CI><D-8(BCWD8(Y^:
M+8\_A>^/D?GBJ2TJJ6]!A+SK5C5=.P62%NZ3LK?[V9MA;;_K8J:6[/SI/'GL
M#1"L*M0$NH:N_/3%^:OF]8-MH8H^2\#$7R(Z?\N=.RKZM&OK4A<.%WX*TFQZ
MX'NQ5%*4?W3B&X"X7>R.+FS]"7>W/93I@9E,/=/YG[18$KO1TB_IGPA,Q:6R
MEZS_Z3.95_=G,@C.SX^_XB'_BY#_#U!+ P04    "  1.!5;9\H74D4$  "%
M$0  $@   '-C;'AW+3(P,C4P.#$V+GAS9,U7WU/;.!!^[TS_!]5/=S-G*S9'
M6SQ ARMPPPQ0)J3MO3&*O4DTE26?)$/X[V\EV\'Y00B!NQXOR-K]=O?;7:V4
M_4_30I!;T(8K>1#$42\@(#.5<SD^""H3,I-Q'GPZ?/MF_UT8DN/3LTL2DHFU
MI4DIO;N[B_(1ET:)RJ(%$V6JH"0,6_W/@Z_D6VT])7T0P R09#=.R!\5%WF:
M])+=WH<DB>(N2 -SUDC.+*3D(TUBZA3)7II\2'=VR=$%.6'&@I9DP OH0E5Y
MK_EX8LDOV:_$@XZ5E" $W)-3+IG,.!/DNHWW-W(FLX@<"4'Z#F8P2 /Z%O*H
ML3HU>6JR"13L[1M",%O2I!)-5L5!X-+09&$ZU")2>DQSJZF]+X&B4HA:H'D6
M=*!/XY8P6 8G,3/@B)FA![42GYX.PF1B>C=3QQ19S:<1Y&.F0R4%E^ +Y;/_
M,7[?0>; 9S@?FX$L&JM;BH)%+T[.5[-)>KT=BGUA,>'0@:#K'VL03CS$%NDZ
M68+<[7A O+>W1[UT(:3<SC-HK._26CB?V#%CY<J\.L$#868Q@\/*PJG2Q3&,
M6"702R7_KIC@(PZYU\+^+D#:.9UY#<OT&.PE*\"4+(.M2H0=N2H?2#&F?UV<
M7_MF#0X=@!#?O[PHE;:D;N-SE?G3M:8,[BMLJQ>ZK3!.PITX0F,!D4O1KRD]
MH2\.I&V*K0*9==3&@9C'.M\M0K=XS/OJ\[)U!A8G@N._Y_C'[S?BOS117B$2
M)2]?&DQG+&Y?$\EX5D^]>KEY71Z0+^K-=IJX/*QWO#A^GD]ZY5BB(*QI=];2
M7SW57CL,?P]M'$?GUFH"\6$P*97UOKO!L;+D<J2:+=QTASIM3W8?1L1? RG3
MF58"UE\6M-2J!&TY^G\8#K6!B8;10> OS[ =O#>"#2,<O*W.DH?Y>>/$%"$@
MSA_B:[&66P<^=V+BY/C^8&)FVB4%W6,M1&=>_==\2PW/Y8L0@_>>+]SCM*\Z
M6O];]CF,GLL>(5SR]=R/9SK/9NY\#%"#N,77_MG3;X;9HX%:-E52%?=UH,<J
MJ]S[I/U_)/,3B0'>G^'ITH4O3$ XOB[ZJ'ZSD?HLV#;<AVP<QCWWAS\76@O=
M)9,YJ<V1CKU]NFADT7YE(/\B#_TZ8R*KQ*SM&G"CL0ZXV+";(^>+O1K7[+:%
M:T<979QES<[\S/,3KWE(^EKX!KU95X0!&[K&<1,7.^UIQ;K?_.L]-=A"<GQF
MH7"A!L140X,H_^OH3ZVJLE;,;3I!N<ZJ(3AE;%T/QRVN\H$WF%>Z:2')A7"N
M#@*K*S3*T*9FF6V_Z;9,,>?>O=F$;4=Y"\8\Y?\NS\^J*)2\MBK[<<7T-R8J
MZ$5X7N(KT-<3IN$"BB'HENG&ZC77^B=JFJN"<?GSR7YG6C-IS4!=53J;X(SL
M\#G"\IU,L;FX@2M\%\*7T>^])-KMK<[$Z]CZF6FJ#W[]V,+/?P!02P,$%
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MG%A=FI_^[/QWOOZQU--/@M3#?U!+ P04    "  1.!5;"Q<-K38(  #-6@
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M3)$A@?9V90V%YBWI6BW.N'FZ#A9*+:VR&M&>V_#X:17"BV,PQM%=/.RQ-&/
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MMHS>!GL9TP%_-K]PW%PQ_\SO]73)/U!+ 0(4 Q0    ( !$X%5MIL>5H"BT
M +;E   -              "  0    !D,C<P,3%D.&LN:'1M4$L! A0#%
M  @ $3@56[NW7+8M'   &'(  !               ( !-2T  &0R-S Q,61E
M>#DY,2YH=&U02P$"% ,4    "  1.!5;9\H74D4$  "%$0  $@
M    @ &020  <V-L>'<M,C R-3 X,38N>'-D4$L! A0#%     @ $3@56T3[
MP+\-!@  6S8  !8              ( !!4X  '-C;'AW+3(P,C4P.#$V7V1E
M9BYX;6Q02P$"% ,4    "  1.!5;"Q<-K38(  #-6@  %@
M@ %&5   <V-L>'<M,C R-3 X,39?;&%B+GAM;%!+ 0(4 Q0    ( !$X%5NC
MN146SP4  "8Z   6              "  ;!<  !S8VQX=RTR,#(U,#@Q-E]P
<<F4N>&UL4$L%!@     &  8 A0$  +-B      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>d27011d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sclxw="http://imetrix.edgar-online.com/20250816"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sclxw-20250816.xsd" xlink:type="simple"/>
    <context id="duration_2025-08-16_to_2025-08-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820190</identifier>
        </entity>
        <period>
            <startDate>2025-08-16</startDate>
            <endDate>2025-08-16</endDate>
        </period>
    </context>
    <context id="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820190</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sclxw:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-16</startDate>
            <endDate>2025-08-16</endDate>
        </period>
    </context>
    <context id="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820190</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sclxw:WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-16</startDate>
            <endDate>2025-08-16</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2025-08-16_to_2025-08-16"
      id="Hidden_dei_EntityRegistrantName">Scilex Holding Co</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-345">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-08-16_to_2025-08-16"
      id="Hidden_dei_EntityCentralIndexKey">0001820190</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-372">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-373">2025-08-16</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-374">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-375">001-39852</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-376">92-1062542</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-377">960 San Antonio Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-378">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-379">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-380">94303</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-381">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-382">516-4310</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-383">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-384">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-385">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-386">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-CommonStockParValue0.0001PerShareMember"
      id="ixv-387">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-CommonStockParValue0.0001PerShareMember"
      id="ixv-388">SCLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-CommonStockParValue0.0001PerShareMember"
      id="ixv-389">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember"
      id="ixv-390">Warrants to purchase common stock at an exercise price of $402.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember"
      id="ixv-391">SCLXW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-08-16_to_2025-08-16_us-gaap-StatementClassOfStockAxis_sclxw-WarrantsToPurchaseCommonStockAtAnExercisePriceOf402.50PerShareMember"
      id="ixv-392">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-393">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2025-08-16_to_2025-08-16" id="ixv-394">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
